MedPath

A clinical trial to study the effect of two therapies, Nasya and Matra Basti with Shatapushpa Taila in patients with polycystic ovarian syndrome (Artava Kshaya)

Not Applicable
Conditions
Health Condition 1: E282- Polycystic ovarian syndrome
Registration Number
CTRI/2022/07/043894
Lead Sponsor
ttarakhand Ayurved University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Females of reproductive age 16-40 yr

2. Patient diagnosed with signs and symptoms of PCOS

3. Patients fit for Matra Basti and Nasya Karma

Exclusion Criteria

1. CAH

2. Thyroid dysfunction

3. Cushing syndrome

4. Hyperprolactinemia

5. Known case of any organic lesions of reproductive tract like tuberculosis,

carcinoma and congenital deformities, or any pelvic pathology

6. Any complicated or severe Systemic illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o improvement: 0-25% <br/ ><br>Mild improvement: 26-50% <br/ ><br>Moderate improvement: 51-75% <br/ ><br>Marked improvement: 76-100% <br/ ><br>Timepoint: 0th, 30th, 60th, 90th day <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Exacerbation in signs and symptomsTimepoint: 90 days
© Copyright 2025. All Rights Reserved by MedPath